Gapping up
In reaction to earnings/guidance:
- LII +4.9%, PSO +3.1%, OTIS +2.4%, CBU +2%, CHKP +1.2%
Select airline related names showing strength:
- AAL +2.3%, DAL +2.1%, UAL +1.8%, JETS +1%, LUV +0.8%, SAVE +0.8%, .
Other news:
- QURE +12.8% (announces FDA removes clinical hold on hemophilia B gene therapy program)
- BWAY +12.1% (FDA granted 501(k) clearance for its Theta Burst three-minute protocol utilizing its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) system for the treatment of major depressive disorder)
- AXSM +12% (announces FDA acceptance and priority review of new drug application for AXS-05 for treatment of major depressive disorder)
- IMNM +11.7% (SARS-CoV-2 antibody cocktail neutralizes UK, South Africa, Brazil and California variants in preclinical testing; progressing towards IND filing; also enters $27 mln private placement)
- SEAH +7.1% (Super Group to combine with Sports Entertainment Acquisition Corp to create NYSE-listed global gaming company)
- CAN +5.2% (files mixed securities shelf offering)
- FBC +4.1% (New York Community Bancorp (NYCB) to acquire FBC)
- TALO +3.5% (files for 10,655,012 share common stock offering by selling shareholders)
- IMAB +2% (announced topline results from its phase 2 study evaluating olamkicept in patients with active ulcerative colitis)
- BRKS +1.8% (to acquire Precise Automation)
Analyst comments:
- BC +1.8% (upgraded to Buy from Neutral at Citigroup)
- DFS +1.8% (upgraded to Buy from Neutral at BofA Securities)
- SPG +1.5% (upgraded to Outperform from In-line at Evercore ISI)
- PFPT +0.9% (upgraded to Buy from Hold at Summit Insights)